Showing 28,281 - 28,300 results of 49,954 for search '(( 50 ((a decrease) OR (mean decrease)) ) OR ( a ((fold decrease) OR (point decrease)) ))', query time: 1.15s Refine Results
  1. 28281
  2. 28282

    Infectivity of <i>LdASS</i> mutants in the murine model. by Abul Hasan Sardar (573177)

    Published 2016
    “…The parasite burden in spleen was found to decrease by ~4 fold in <i>LdASS</i><sup>-/-/+</sup> cell line but increased by ~2.3-fold in OE cell line compared to WT and VC cell lines. …”
  3. 28283

    Effects of RNA on S/MAR-selective binding of hnRNP U. by Mary Miyaji (16764659)

    Published 2023
    “…The decrease in aggregated DNA at 1x fold RNA was statistically significant by Student’s <i>t</i> test (marked by asterisk, <i>p</i><0.01). …”
  4. 28284

    PSTH histograms of the single population firing rate model during the simulated working memory task. by Sergio Verduzco-Flores (371239)

    Published 2013
    “…The delay firing rate does not correspond to a stable state, but the decay towards the baseline state is sufficiently slow so that no significant decrease in firing rate occurs by the end of the period. …”
  5. 28285

    Reduction of trained cFL models. by Melody K. Morris (115320)

    Published 2011
    “…Thus, a selection threshold of 5×10<sup>−4</sup> to 7.6×10<sup>−3</sup> results in the models at the “filter points” noted in (a).…”
  6. 28286

    Mannitol uptake is repressed in vitro, but mannitol reaches <i>S</i>Tm inside host cells without affecting the host or bacterial metabolism. by Karin Mitosch (16851651)

    Published 2023
    “…Dashed lines show a 2-fold increase/decrease. (H) Fold change in CFUs of <i>S</i>Tm in the <i>glpD</i> mutant compared to the wt at 12 hpi in RAW264.7 cells with or without the addition of mtl or glyc. …”
  7. 28287
  8. 28288
  9. 28289
  10. 28290

    Piroxicam and vehicle control do not impact canine UC cells <i>in vitro</i>. by Jordon M. Inkol (11237604)

    Published 2021
    “…<p>Representative IC50 curves for piroxicam treatment of AXA, Orig, and SH cells show no dose dependent decrease in cell viability up to 1mM (A). …”
  11. 28291
  12. 28292

    Pharmacological blockade of K<sub>ATP</sub> channels negates the hippocampal synaptic and neuronal protection afforded by ketones. by Do Young Kim (131974)

    Published 2015
    “…Asterisks denote significant differences between experimental groups and the control at a specific time-point (*** <i>p</i> < 0.001). The dotted line indicates the mean PS amplitude of the control group. …”
  13. 28293

    Surface Modifications of an Organic Polymer-Based Microwire Platform for Sustained Release of an Anti-Inflammatory Drug by Chuan Liu (367528)

    Published 2020
    “…In general, a decrease in fold-change expression was observed for all genes tested for Dex-loaded wires compared with controls (functionalized but no drug). …”
  14. 28294

    Surface Modifications of an Organic Polymer-Based Microwire Platform for Sustained Release of an Anti-Inflammatory Drug by Chuan Liu (367528)

    Published 2020
    “…In general, a decrease in fold-change expression was observed for all genes tested for Dex-loaded wires compared with controls (functionalized but no drug). …”
  15. 28295

    Histone 3 acetylation correlates with target gene expression of Srf and Gata4. by Jenny Schlesinger (229807)

    Published 2011
    “…Expression levels (A, E) and fold changes (F) are represented as box plots. …”
  16. 28296

    dFmr1 regulates heart rate. by Stefanie Mares Novak (826953)

    Published 2015
    “…<b>(B)</b> Loss of dFmr1 (<i>dFmr1</i><sup><i>3/50M</i></sup>, N = 16) results in a statistically significant decrease in heart rate when compared to wild type (<i>w</i><sup><i>1118</i></sup>, N = 10). …”
  17. 28297

    Heat map of metabolites measured across the IL collection during season I. by David Toubiana (175451)

    Published 2012
    “…Blue rectangles indicate a significant decrease in metabolite content, and red rectangles, a significant increase in metabolite content. …”
  18. 28298
  19. 28299
  20. 28300

    Cell viability after ganetespib, ganetespib with Torin2 and ganetespib with rapamycin treatment. by Evelyn M. Mrozek (10692391)

    Published 2021
    “…All TSC1 or TSC2 deficient tumor cell lines showed a strongly decreased cell viability after treatment with ganetespib. …”